BioInfect returned to The Spine in Liverpool for the second year in a row on 5th February, with over 175 delegates, 14 exhibitors and 15 poster abstracts focusing on the issues surrounding the increasing threat of AMR and how it can be addressed. An informal Biotech & Beers meetup held locally the night before was also well-attended and provided an opportunity for attendees to maximise their networking.
Read the full event summary here
BioInfect 2025 is supported by Evotec, iiCON, Appleyard Lees, the Liverpool School of Tropical Medicine and ReNewVax.
Agenda highlights:
Keynote Speakers
Jef Grainger, Associate Director, Research Strategy and Programmes, BBSRC
Erin Duffy, Chief of Research and Development, CARB-X
Lloyd Payne, Drug Discovery Executive, Kineticos Life Sciences
State of the Possible Panel
Chair: Becky Jones-Phillips, Director of Enterprise and Innovation, Liverpool School of Tropical Medicine
Speakers
Colin Brown, Deputy Director of Clinical & Emerging Infections at UK Health Security Agency
Jonathan O’Halloran, CEO, QuantuMDx
Peter Jackson, CEO, Infex Therapeutics
Seamus Coyle, Consultant in Palliative Medicine, The Clatterbridge Cancer Centre NHS Foundation Trust
Jane Freeman, Co-Deputy Theme Lead for AMRI, NIHR Leeds Biomedical Research Centre
iiCON – UKRI Fund Pilots Projects
Speakers
Farhad Ahmed, Head of Strategic Partnerships, LYVA Labs
Charlotte Hemingway, Post Doctoral Research Associate, Liverpool School of Tropical Medicine
Martin Scurr, Chief Scientific Officer, Immunoserv
Catrin Moore, Reader in Global Health and Infectious Diseases, City St George's University of London
Ruoxiao Xie, Lecturer of Bioengineering, University of Liverpool
Craig Williams, Co-Founder, CCI Photonics
Jon Austyn, Chief Scientific Officer, Iuvantium
Poster Competition Results
Chair: Pia Thommes, Expert Biologist - Infectious Diseases
Keeping PACE with AMR: one year on - early-stage projects and enabling collaborations
Beverley Isherwood, PACE Director & Strategy Leader – Infectious Diseases
Hot Topics - What's in the pipeline
Chair: Neil Murray, CEO, ReNewVax
Speakers
Carrie Ambler, CSO & Founder, LightOx
Michael Murray, Executive Chairman and CEO, MetalloBio
Daniel Walker, CSO & Co-Founder, GLOX Therapeutics
Funding and Investment in AMR - How the North can take the lead
Chair: Kate Hickinson, Partner, Appleyard Lees
Speakers
Janet Hemingway, Founding Director, iiCON
Lloyd Payne, Drug Discovery Executive, Kineticos Life Sciences
Phil Packer, Innovation Lead AMR and Vaccines, SRO for PACE, Innovate UK
Ian Smith, Head of Investor Partnerships, CPI Enterprises
Increasing the Engagement of Young People with the issue of Antimicrobial Resistance (AMR)
Dr John Dyer and Students, Liverpool Life Sciences UTC
